FDA Approves Second Generic Version of Mifepristone Amid Political Controversy

On September 30, 2025, the U.S. Food and Drug Administration (FDA) approved a new generic version of the abortion pill mifepristone, produced by Evita Solutions LLC. This approval allows Evita Solutions to manufacture 200 mg mifepristone tablets, which are indicated for terminating pregnancies up to 10 weeks gestation. The FDA's decision was communicated in a letter to Evita, confirming that the generic drug is bioequivalent to the original brand, Mifeprex, produced by Danco Laboratories. This marks the second generic version of mifepristone approved by the FDA, following the first generic approval in 2019 for GenBioPro.

Despite promising safety review, FDA approves another generic abortion pillFDA approves mifepristone generic as political abortion war rages onFDA Approves Generic Mifepristone Tablets for AbortionKSAZ - Fox 10 PhoenixMedpage TodayNew Tang Dynasty

The approval has ignited significant backlash from anti-abortion advocates and some Republican lawmakers. Critics, including former Vice President Mike Pence and Senator Josh Hawley, have labeled the decision a "betrayal" of the pro-life movement. Pence called for the resignation of Health and Human Services Secretary Robert F. Kennedy Jr., arguing that the approval undermines the pro-life policies that many supporters of Trump expected. Hawley expressed his discontent on social media, stating he has "lost confidence" in the FDA's leadership, emphasizing that the agency had promised a comprehensive safety review of mifepristone prior to approving new versions.

Newsweek

The approval comes at a time when the Trump administration is under pressure from conservative groups to restrict access to abortion medications. Health Secretary Kennedy and FDA Commissioner Dr. Marty Makary had previously committed to reviewing the safety of mifepristone, following concerns raised by a study from the Ethics and Public Policy Center, which suggested potential adverse effects from the drug.

Trump FDA Approves Generic Abortion Pill Amid Safety Probe (2)The IndependentNewsweekUnited Press International (UPI)FDA Quietly Approves Another Generic Formulation of Abortion Drug MifepristoneDaily Beast

In contrast, supporters of the approval, including reproductive rights organizations, argue that mifepristone has been safely used for over two decades and is critical for women's health. Mini Timmaraju, president of Reproductive Freedom for All, stated that the FDA's decision reflects the agency's commitment to following scientific evidence and ensuring access to safe medication. Major medical organizations, such as the American Medical Association, continue to advocate for unrestricted access to mifepristone, asserting that restrictions are not supported by scientific data.

KSAZ - Fox 10 Phoenix

Despite the approval of the new generic, access to mifepristone remains limited in many states due to various abortion bans and restrictions. Approximately two-thirds of abortions in the U.S. are conducted using medication, primarily mifepristone in combination with misoprostol. The approval of the second generic version is not expected to significantly alter access, as ongoing legal challenges continue to affect the availability of abortion medications in numerous jurisdictions.

NewsweekFDA Approves Generic Mifepristone Tablets for AbortionMedpage TodayNew Tang DynastyUsNews and World ReportKSAZ - Fox 10 Phoenix

Andrew Nixon, a spokesperson for HHS, emphasized that the FDA has limited discretion in approving generic drugs, stating, "By law, the Secretary of Health and Human Services must approve an application if it demonstrates that the generic drug is identical to the brand-name drug." He also noted that HHS is conducting a study on reported adverse effects to ensure the FDA's risk mitigation program is adequate.

NewsweekPoliticoTrump FDA Approves Generic Abortion Pill Amid Safety Probe (2)FDA Quietly Approves Another Generic Formulation of Abortion Drug MifepristoneNewsweek

• “This reckless decision by the FDA to expand the availability of abortion drugs is unconscionable,” — Marjorie Dannenfelser, President of Susan B. Anthony Pro-Life America

Trump FDA Approves Generic Abortion Pill Amid Safety Probe (2)

• “FDA had promised to do a top-to-bottom safety review of the chemical abortion drug, but instead they’ve just greenlighted new versions of it for distribution.” — Senator Josh Hawley (R-MO)

Newsweek

• “Reproductive Freedom for All president and CEO Mini Timmaraju said: “This is exactly how our system is supposed to work, and it has worked this way for decades.” — Mini Timmaraju, President of Reproductive Freedom for All

FDA approves mifepristone generic as political abortion war rages on

• “1,4 “The FDA has very limited discretion in deciding whether to approve a generic drug.” — Andrew Nixon, HHS Spokesperson

FDA Approves Generic Mifepristone Tablets for Abortion

The FDA's approval of Evita Solutions' generic mifepristone has intensified the ongoing debate over abortion access in the United States, highlighting the intersection of healthcare and political ideology. As the Trump administration navigates pressures from both sides of the abortion debate, the implications of this decision will continue to unfold in the context of state-level restrictions and ongoing legal challenges.

Newsweek